ab medica s.p.a. sviluppa e diffonde i prodotti medicali più innovativi nei settori della Robotica, Chirurgia mininvasiva, Cardiologia interventistica, Radiologia, Anestesia e Rianimazione.

newsletter

e-mail

Rassegna stampa

« UNA MISSIONE CHE DEVE ESSERE PORTATA AVANTI | Main | AUTORIZZATI "GRANDI ACQUISTI" A VERONA, BASSANO, MESTRE IN ARRIVO 3 NUOVE ECCELLENZE AL SERVIZIO DEI PAZIENTI »

Rassegna stampa

CYBERKNIFE® RADIOSURGERY FOR LUNG CANCER SEES INCREASED INTEREST AND CONTINUED RAPID GROWTH

ACCURAY.com - 02.03.2009
Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today significant growth in CyberKnife lung cancer treatments in calendar year 2008. The number of lung cancer patients treated with CyberKnife radiosurgery in the United States grew 52 percent from calendar year 2007 to 2008 and 43 percent worldwide. Additionally the overall number of patients treated with CyberKnife radiosurgery grew to more than 60,000 patients - a 14 percent increase from calendar year 2007 to 2008, demonstrating the increasing awareness and continued rapid adoption of CyberKnife radiosurgery, with lung being the leading extracranial indication by utilization in calendar year 2008.
Leggi l'articolo